Skip to main content
. 2023 May 5;14:1182454. doi: 10.3389/fimmu.2023.1182454

Figure 2.

Figure 2

Blood sNLRP3 levels vary in different clinical conditions in COVID-19 patients. (A) patients with fever and respiratory symptoms at debut (n=42); (B) patients who required hospitalization in Pneumology division (n=38); (C) patients who required mechanical ventilation (n=25); (D) patients who required hospitalization in Intensive care unit (ICU) (n=10); (E) patients who died during hospitalization (n=10). Data are means ± SE (standard error). Comparisons between groups were performed using Mann-Whitney U test. A two-sided p-value ≤0.05 was considered statistically significant. sNLRP3: soluble nucleotide-binding oligomerization domain (NOD), leucine-rich repeat (LRR)-containing protein (NLRP) 3.